Drug-drug liver injury in patients NAFLD with COVID-19

被引：0
作者：
Pavlov, A. [1 ]
Karakozov, A. [2 ]
Molodova, A. [2 ]
Denisova, O. [3 ,4 ]
Kazakov, S. [3 ,4 ]
机构：
[1] AA Vishnevsky Natl Med Res Ctr High Med Technol, Moscow, Russia
[2] Russian Univ Med, Minist Hlth Russian Federat, Fed State Budgetary Educ Inst Higher Educ, Moscow, Russia
[3] Fed Med & Biol Agcy Russia, Fed State Budgetary Inst, Fed Sci & Clin Ctr Specialized Types Med Care & M, Moscow, Russia
[4] Russian Assoc Med Lab Diagnost, Moscow, Russia
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.119231
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1269
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [31] Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview
    Rezaee, Haleh
    Pourkarim, Fariba
    Pourtaghi-Anvarian, Samira
    Entezari-Maleki, Taher
    Asvadi-Kermani, Touraj
    Nouri-Vaskeh, Masoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (01):
  • [32] Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications
    Jain, Shreshta
    Potschka, Heidrun
    Chandra, P. Prarthana
    Tripathi, Manjari
    Vohora, Divya
    EPILEPSY RESEARCH, 2021, 174
  • [33] A cross-sectional study on the potential drug-drug interaction risk of COVID-19 patients in hospital
    Huang, Liu-Lyu
    Jiang, Bo
    Han, Yong-Long
    Liu, Ying
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2024, 62 (07) : 311 - 318
  • [34] Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir
    Brandariz-Nunez, David
    Correas-Sanahuja, Marcelo
    Guarc, Eva
    Picon, Rafael
    Garcia, Barbara
    Gil, Rocio
    MEDICINA CLINICA, 2020, 155 (07): : 281 - 287
  • [35] Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapy
    Igho-Osagie, Ebuwa
    Puenpatom, Amy
    Williams, Marissa Grifasi
    Song, Yan
    Yi, Denise
    Wang, Jessie
    Berman, Richard
    Gu, Miley
    He, Chujun
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (05) : 509 - 518
  • [36] Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
    Zhaoyan Chen
    Fangyuan Tian
    Ya Zeng
    BMC Geriatrics, 23
  • [37] Risk of drug-drug interactions in China's fight against COVID-19 and beyond
    Zhang, Qingpeng
    Yang, Jiannan
    Zeng, Daniel Dajun
    Feng, Yibin
    Wong, Ian C. K.
    PHARMACOLOGICAL RESEARCH, 2023, 196
  • [38] Drug-drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date
    Ellis, Camden
    Inaba, Keita
    van de Vuurst, Christine
    Ghrayeb, Atheel
    Cory, Theodore James
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (11) : 795 - 806
  • [39] Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated Study
    Boppana, Ujwal
    Leonard, Thomas S.
    Jolayemi, Ayodeji
    Ansari, Maliha I.
    Salib, Andrew
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [40] Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
    Chen, Zhaoyan
    Tian, Fangyuan
    Zeng, Ya
    BMC GERIATRICS, 2023, 23 (01)
12345